Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration.

Anny M Cheng, Sunir Joshi, Raphael G Banoub,Jackson Saddemi,Kakarla V Chalam

Cureus（2023）

引用 0|浏览1

暂无评分

摘要

Faricimab has proven to be an effective treatment for nAMD patients resistant to other anti-VEGF agents. It demonstrates significant anatomical improvement and vision preservation in this challenging patient population.

查看译文

关键词

central subfield thickness, vabysmo, subretinal fluid, refractory namd, intravitreal anti-vascular endothelial growth factor, intraretinal fluid, faricimab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要